Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced that it has received a successful response to its recent Type C meeting request from the U.S ...
Chugai obtains MHLW approval for FoundationOne CDx Cancer Genomic Profile as companion diagnostic of Alecensa for ALK fusion gene-positive solid tumours: Tokyo Tuesday, May 19, 20 ...
A study led by Dr. John Kopchick and his graduate student, Dr. Arshad Ahmad, found a potential new way to treat cancer. This ...
AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance ...
India launches a seven-minute lung cancer immunotherapy injection Tecentriq that may improve patient comfort and reduce ...
RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 10:00 AM EDTCompany ParticipantsLavina Talukdar - Senior VP ...
MarketBeat on MSN
Adagene spotlights ADG126 strategy as masked CTLA-4 trial advances in colorectal cancer
Adagene (NASDAQ:ADAG) Chief Strategy Officer Mickael Chane-Du outlined the company's clinical strategy for its lead antibody ...
Join PanCAN on Thursday, June 25, at 11 a.m. PT / 2 p.m. ET, for a webinar focused on KRAS and pancreatic cancer. Our panel ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), will present new data from nine approved and investigational medicines across more than 15 indications at the 2026 American Society ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results